melasma. Other melanin hyperpigmentation
Conditions
Interventions
Intervention group: Approving a formulated topical cream containing Ginger on patient with mild to moderate melasma.
Sponsors
Sina Trading Company
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Cases of mild to moderate melasma (MGSC=1& 2) General health Signing the consent form for participation in the study
Exclusion criteria
Exclusion criteria: Documented allergies to components of cream Use of topical lightening products like AHA ,BHA and retinoid component within 21 days prior to the study Active skin disease at test area: rosacea, atrophy, acne and eczema Pregnancy or lactating Use of systemic corticosteroid and isotretinoin within 28 days prior to the study History of laser treatment or dermabrasion or deep facialpeels within the past 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Modified melasma severity index. Timepoint: Before intervention, 6 and 12weeks after intervention and 3 months after stop using. Method of measurement: mMASI. | — |
Secondary
| Measure | Time frame |
|---|---|
| Size and amount of skin spots. Timepoint: Before intervention, 6 and 12 weeks after using and 3 months after stop using. Method of measurement: Visio face.;Melanin content changes. Timepoint: Before intervention,6 and 12 weeks after using and 3 months after stop using. Method of measurement: mexameter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAnise Samadi
Tehran University of Medical Sciences
Outcome results
None listed